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zation of health services. The overall C/B ratio turned out
to be 1:6.52, in other words, compared to control group,
asthma education programs reduce direct medical costs by
$6.52 for each dollar spent in providing the education.
CONCLUSION: Our study shows that the asthma educa-
tion programs are beneficial in reducing the direct medical
costs associated with asthma. These findings suggest that
education programs benefit the patient and lead to their
well being which in turn will benefit both the patient and
the third-party payers.
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THE FIRST PHARMACOECONOMIC STUDY IN 
ASTHMA: SOME IMPORTANT OBSERVATIONS
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Treatment options for control of asthma are numerous.
However, as for other diseases, there are often differences
between clinical trials and what takes place in clinical
practice. 
OBJECTIVES: To present some methodological issues in
relation to the first “real-life” pharmacoeconomics study
(PECT) in asthma, comparing the cost-effectiveness of
budesonide Turbuhaler versus sodium cromoglycate Spin-
haler for moderately asthmatic children, aged 5–11 years. 
METHODS: One hundred thirty-eight Swedish patients
were randomized to one of the two treatments. Patients
were then treated according to local clinical practice on
an open basis for 12 months. Thus, any additional ther-
apy was allowed, including switching to the comparator.
The objective was to reach the same degree of patient
asthma control in both groups. There were six scheduled
study visits. Efficacy (asthma control) and resource use
were recorded in patient diaries and case report forms. 
RESULTS: 1) A number of problems in relation to ran-
domization, such as center effects and sample selection
bias, were experienced. 2) A dilution of difference in effect
was experienced due to the fact that 36% of patients on
sodium cromoglycate had to switch to budesonide because
of poor control of asthma (as judged by the physician). 3)
Because there was insufficient data available on which to
base a power calculation, too few patients were recruited.
4) Due to large standard deviations and the problems
listed above, a significant advantage in budesonide costs
could only be identified when various background factors
were taken into account in a multiple regression analysis. 
CONCLUSIONS: A number of different methodological
problems compared to ordinary piggy-back economic
evaluations arise in PECTs. Careful consideration of de-
sign is necessary to ensure high-quality research. Innova-
tive methodological approaches, such as multiple regres-
sion analysis, are required.
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OBJECTIVE: To evaluate the importance of accounting
for correlations between observations when analyzing re-
peated measures of healthcare utilization. 
METHODS: Poisson regression was applied with and with-
out generalized estimating equations to analyze -agonist
use, healthcare contacts, and nocturnal awakenings in
chronic asthmatics in two large similarly designed, 12-week,
randomized trials of Montelukast, a once daily leukotriene
receptor antagonist, compared to placebo. Data on -ago-
nist use and nocturnal awakenings were recorded on daily
diary cards. Healthcare contacts included visits to physi-
cians, the emergency room, and hospitalizations docu-
mented as not mandated by the protocols. 
RESULTS: Montelukast compared to placebo decreased
the rate of days of -agonist use by 9.6% (p  0.0001),
nights with awakenings by 22.5% (p  0.0001) and
healthcare contacts by 23.0% (p  0.09) when analyzed
without generalized estimating equations. Use of general-
ized estimating equations did not change the parameter
estimates for any of the health outcomes measured, but
did increase the standard errors and confidence intervals
in all cases. The increase in the standard errors ranged
from 19.1% to 355.1%. -agonist use and nights with
awakenings remained statistically significant. However,
healthcare contacts became less significant (p  0.16). 
CONCLUSION: Failure to account for correlations be-
tween observations may lead to erroneous conclusions
based on significance levels that are too small. In large
samples, exceeding 100–200 patients, generalized estimat-
ing equations provide one method of obtaining correct sig-
nificance levels and confidence intervals when data are
correlated. The example above included daily values for
12 weeks in 1300 patients. Other methods of adjusting for
correlated data are needed in smaller samples.
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OBJECTIVES: Healthcare providers need accurate infor-
mation about all aspects of healthcare delivery. Clinical
trials provide useful information concerning the clinical
efficacy of treatment, but they are not representative of
the routine conditions with which patients must contend
when following treatment regimens. Database studies are
being used increasingly to provide information about pa-
tient adherence under routine conditions. 
